
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies to steer clear of and a few better alternatives.
Bentley Systems (BSY)
Trailing 12-Month Free Cash Flow Margin: 31.1%
Pioneering the concept of "digital twins" for infrastructure projects long before it became an industry buzzword, Bentley Systems (NASDAQ: BSY) provides software solutions that help engineers design, build, and operate infrastructure projects across sectors including roads, bridges, utilities, mining, and industrial facilities.
Why Are We Hesitant About BSY?
- Average ARR growth of 12.3% over the last year has disappointed, suggesting it’s had a hard time winning long-term deals and renewals
- Projected sales growth of 11.1% for the next 12 months suggests sluggish demand
- Operating margin didn’t move over the last year, showing it couldn’t increase its efficiency
Bentley Systems is trading at $31.35 per share, or 5.6x forward price-to-sales. If you’re considering BSY for your portfolio, see our FREE research report to learn more.
Macy's (M)
Trailing 12-Month Free Cash Flow Margin: 4.6%
With a storied history that began with its 1858 founding, Macy’s (NYSE: M) is a department store chain that sells clothing, cosmetics, accessories, and home goods.
Why Do We Avoid M?
- Store closures and disappointing same-store sales suggest demand is sluggish and it’s rightsizing its operations
- Poor same-store sales performance over the past two years indicates it’s having trouble bringing new shoppers into its brick-and-mortar locations
- Earnings per share have contracted by 10.7% annually over the last three years, a headwind for returns as stock prices often echo long-term EPS performance
At $23.30 per share, Macy's trades at 10.8x forward P/E. Dive into our free research report to see why there are better opportunities than M.
U.S. Physical Therapy (USPH)
Trailing 12-Month Free Cash Flow Margin: 7.9%
With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE: USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States.
Why Does USPH Fall Short?
- Modest revenue base of $812.2 million gives it less fixed cost leverage and fewer distribution channels than larger companies
- Earnings per share fell by 5.1% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
- Eroding returns on capital suggest its historical profit centers are aging
U.S. Physical Therapy’s stock price of $85.70 implies a valuation ratio of 28.4x forward P/E. Read our free research report to see why you should think twice about including USPH in your portfolio.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

